IMOPX
Price
$3.74
Change
-$0.17 (-4.35%)
Updated
Dec 18 closing price
PMAQX
Price
$44.59
Change
-$1.66 (-3.59%)
Updated
Dec 18 closing price
Ad is loading...

IMOPX vs PMAQX

Header iconIMOPX vs PMAQX Comparison
Open Charts IMOPX vs PMAQXBanner chart's image
Voya MidCap Opportunities Port S2
Price$3.74
Change-$0.17 (-4.35%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$44.59
Change-$1.66 (-3.59%)
VolumeN/A
CapitalizationN/A
IMOPX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IMOPX vs. PMAQX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMOPX is a StrongBuy and PMAQX is a Hold.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.4B vs. IMOPX (1.18B). PMAQX pays higher dividends than IMOPX: PMAQX (0.10) vs IMOPX (0.00). IMOPX was incepted earlier than PMAQX: IMOPX (16 years) vs PMAQX (8 years). IMOPX is a more actively managed with annual turnover of: 74.00 vs. PMAQX (10.10). IMOPX (0) and PMAQX (0) have matching initial minimum investment requirements. IMOPX (22.57) and PMAQX (21.78) have marching annual gain over last year. PMAQX return over 5 years is better than : 50.76 vs. IMOPX (-69.20).
IMOPXPMAQXIMOPX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years8 years-
Gain YTD21.42920.631104%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.18B29.4B4%
Annual Yield % from dividends0.000.10-
Returns for 1 year22.5721.78104%
Returns for 3 years-74.9415.44-485%
Returns for 5 years-69.2050.76-136%
Returns for 10 years-73.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS34.470.81
+2.41%
Aligos Therapeutics Inc
MCW7.37-0.10
-1.34%
Mister Car Wash
ITT149.06-2.64
-1.74%
ITT
GNK14.03-0.58
-3.97%
GENCO SHIPPING & TRADING Ltd
RNAZ6.32-0.42
-6.17%
TransCode Therapeutics Inc